Business Description
CARsgen Therapeutics Holdings Ltd
ISIN : KYG1996C1006
Share Class Description:
CRTHF: Ordinary SharesCompare
Compare
Traded in other countries / regions
02171.Hong KongCRTHF.USA IPO Date
2022-02-18Description
CARsgen Therapeutics Holdings Ltd is a clinical-stage biopharmaceutical company discovering, researching, and developing cell therapies in the People's Republic of China and the United States of America.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.71 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.12 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 15.3 | |||||
| 3-Year EPS without NRI Growth Rate | -27.3 | |||||
| 3-Year FCF Growth Rate | -11.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 12-1 Month Momentum % | -10.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.55 | |||||
| Quick Ratio | 9.54 | |||||
| Cash Ratio | 9.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 4.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -34.34 | |||||
| ROA % | -29.05 | |||||
| ROIC % | -128.05 | |||||
| ROC (Joel Greenblatt) % | -183.61 | |||||
| ROCE % | -31.75 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.93 | |||||
| Price-to-Tangible-Book | 1.94 | |||||
| EV-to-EBIT | -2.57 | |||||
| EV-to-EBITDA | -2.62 | |||||
| EV-to-FCF | -4.12 | |||||
| Price-to-Net-Current-Asset-Value | 2.44 | |||||
| Price-to-Net-Cash | 2.5 | |||||
| Earnings Yield (Greenblatt) % | -38.91 | |||||
| FCF Yield % | -13.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CRTHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
CARsgen Therapeutics Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.187 | ||
| Beta | 0 | ||
| Volatility % | 10.22 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.047788 | ||
| 20-Day SMA ($) | 1.598 | ||
| 12-1 Month Momentum % | -10.22 | ||
| 52-Week Range ($) | 0.9496 - 1.86 | ||
| Shares Outstanding (Mil) | 575.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CARsgen Therapeutics Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CARsgen Therapeutics Holdings Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CARsgen Therapeutics Holdings Ltd Frequently Asked Questions
What is CARsgen Therapeutics Holdings Ltd(CRTHF)'s stock price today?
The current price of CRTHF is $0.95. The 52 week high of CRTHF is $1.86 and 52 week low is $0.95.
When is next earnings date of CARsgen Therapeutics Holdings Ltd(CRTHF)?
The next earnings date of CARsgen Therapeutics Holdings Ltd(CRTHF) is 2024-09-19 Est..
Does CARsgen Therapeutics Holdings Ltd(CRTHF) pay dividends? If so, how much?
CARsgen Therapeutics Holdings Ltd(CRTHF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers